Cwm, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Cwm, LLC
- $28.4 Billion
- Q2 2025
A detailed history of Cwm, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 109,330 shares of LXRX stock, worth $120,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,330
Previous 105,504
3.63%
Holding current value
$120,263
Previous $49,000
110.2%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
199MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$150 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$10.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$10.5 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$9.03 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$4.06 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $208M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...